Oscar Health (OSCR) Return on Sales (2020 - 2026)

Oscar Health's Return on Sales history runs 7 years deep, the most recent figure standing at 0.0% for Q1 2026.

• Quarterly Return on Sales fell 63.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.15%, down 15.0% from the prior year.
• Return on Sales was 0.0% for Q1 2026 at Oscar Health, up from 0.39% in the prior quarter.
• Across five years, Return on Sales topped out at 0.64% in Q1 2025 and bottomed at 0.39% in Q4 2025.
• A 5-year average of 0.02% and a median of 0.03% in 2023 frame the typical range for Return on Sales.
• Annual changes were most pronounced in 2022 — Return on Sales surged 292 bps — and 2026, when it plunged 63 bps.
• Oscar Health's Return on Sales stood at 0.35% in 2022, then jumped by 100 bps to 0.0% in 2023, then slumped by 289 bps to 0.0% in 2024, then plunged by 61258 bps to 0.39% in 2025, then soared by 100 bps to 0.0% in 2026.
• Business Quant data shows OSCR's Return on Sales at 0.0% in Q1 2026, 0.39% in Q4 2025, and 0.16% in Q3 2025.